Sulfinpyrazone after Myocardial Infarction
- 1 June 1978
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 298 (22) , 1257-1259
- https://doi.org/10.1056/nejm197806012982212
Abstract
Correspondence from The New England Journal of Medicine — Sulfinpyrazone after Myocardial InfarctionKeywords
This publication has 16 references indexed in Scilit:
- Cardiac death in the first 6 months after myocardial infarction: Potential for mortality reduction in the early posthospital periodThe American Journal of Cardiology, 1977
- PLATELETS, LIPIDS, AND MYOCARDIAL INFARCTIONThe Lancet, 1977
- Abnormalities of urinary sediment and renal failure following sulfinpyrazone therapyArchives of internal medicine (1960), 1976
- Acute myelomonocytic leukaemia and multiple myeloma after sulphinpyrazone and colchicine treatment of gout.BMJ, 1976
- Prognosis in medically-treated coronary artery disease: influence of ejection fraction compared to other parameters.Circulation, 1975
- Prognosis in coronary artery disease. Angiographic, hemodynamic, and clinical factors.Circulation, 1975
- Factors influencing long-term prognosis after recovery from myocardial infarction—Three-year findings of the Coronary Drug ProjectJournal of Chronic Diseases, 1974
- Prognosis after myocardial infarction. Six-year follow-up.Heart, 1974
- Progress Study of 590 Consecutive Nonsurgical Cases of Coronary Disease Followed 5-9 YearsCirculation, 1973
- Left Ventricular Function in Acute Myocardial Infarction and its Clinical SignificanceCirculation, 1972